Alintosch Pharmaceuticals Private Limited

Alintosch Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1986PTC040884 Incorporated 11 September 1986 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2024
₹32.01 Lakh
▲ 36% YoY
Net loss · FY 2024
₹50.66 Lakh
Net margin -158.3%
EBITDA · FY 2024
₹18.15 Lakh
EBITDA margin 56.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹45 Lakh
Issued & subscribed
Open charges
₹5 Cr
Secured borrowings
Company age
40 yrs
Est. 1986
Directors on board
3
As per MCA filings

About Alintosch Pharmaceuticals Private Limited

Data last updated:

Alintosch Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 September 1986 and has been in existence for over 40 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PTC040884. Its GSTIN is 27AAACA4487A3ZX (Maharashtra). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹45 Lakh. It was formerly known as Alintosch Pharmaceuticals Ltd. It is led by directors including Bharatbhushan Krishnakant Shrikhande and Siddhesh Suresh Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/704 Pramukh Plaza Cardinal Gracious Road Chakala Andheri East, Mumbai, Maharashtra, India – 400069.

As per the financials filed for FY 2024, the company reported a revenue of ₹32.01 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net loss of ₹50.66 Lakh (net margin -158.3%) and EBITDA of ₹18.15 Lakh (EBITDA margin 56.7%). Revenue has grown at a compounded annual rate (CAGR) of 63% over three years and 14% over five years.

As per MCA filings, the company has open charges of ₹5 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230MH1986PTC040884
Registration Number 040884
Incorporation Date 11 September 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Alintosch Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230MH1986PLC040884. The current CIN is U24230MH1986PTC040884, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230MH1986PTC040884Current
U24230MH1986PLC040884Previous

Contact details

Alintosch Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C/704 Pramukh Plaza Cardinal Gracious Road Chakala Andheri East, Mumbai, Maharashtra, India – 400069
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Alintosch Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Alintosch Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Alintosch Pharmaceuticals Private Limited

FY 2025 filings available

Alintosch Pharmaceuticals Private Limited reported revenue of ₹32.01 Lakh (up 36% YoY) for FY 2024.

Revenue · FY 2024
₹32.01 Lakh ▲ 36%
Net loss · FY 2024
₹50.66 Lakh margin -158.3%
EBITDA · FY 2024
₹18.15 Lakh margin 56.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▼ 63%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▼ 69%
5 years · compounded
▲ 22%

Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 36% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹18.15 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹50.66 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin56.7%
Net Profit Margin-158.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Alintosch Pharmaceuticals Private Limited, buy the company report.

Board of directors of Alintosch Pharmaceuticals Private Limited

Alintosch Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Peer comparison

Alintosch Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mebo Pharmaceutical (India) Private Limited₹32.07 Lakh (FY 2025)-9.0%New Delhi, Delhi, India
Moonlight Pharmaceuticals Private Limited₹32.07 Lakh (FY 2017)16.0%Sri Ganganagar, Rajasthan, India
Answer Pharmaceuticals Private Limited₹32.05 Lakh (FY 2024)28.0%Patna, Bihar, India
Alintosch Pharmaceuticals Private Limitedthis company₹32.01 Lakh (FY 2024)-₹50.66 Lakh-158.3%36.0%Mumbai, Maharashtra, India
Alyssum Pharma Private Limited₹31.99 Lakh (FY 2024)-1.0%Bhopal, Madhya Pradesh, India
Mega Biosciences Private Limited₹31.95 Lakh (FY 2024)-24.0%New Delhi, Delhi, India
Taparia Tex Fab Private Limited₹31.94 Lakh (FY 2025)12.0%Mumbai, Maharashtra, India
G 7 Biopharmaceutical Private Limited₹31.94 Lakh (FY 2025)41.0%Wadi, Maharashtra, India

To see the full peer comparison of Alintosch Pharmaceuticals Private Limited, buy the company report.

Auditor

Alintosch Pharmaceuticals Private Limited is audited by J & K AGARWAL & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
J & K AGARWAL & CO.FY 2023100071W

Shareholding

The shareholding of Alintosch Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Alintosch Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹5 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹5.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Sep 2022100642740Others₹5 CrOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Alintosch Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Alintosch Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AAACA4487A3ZXMaharashtraActive25 Oct 2023

To see the full GST registrations and return filing status of Alintosch Pharmaceuticals Private Limited, buy the company report.

Recent activity

Alintosch Pharmaceuticals Private Limited has 7 board changes on record since 1991: 3 appointments and 4 cessations. The latest: Kalpana Suresh Sharma ceased to be Director on 31 Jan 2022.

AGM
Alintosch Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Alintosch Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100642740 was registered on 12 Sep 2022.
Ceased
Kalpana Suresh Sharma ceased to be Director.
Ceased
Sureshkumar Ramnarayan Sharma ceased to be Additional Director.
Ceased
Chandrashekhar Pashupatinath Karundia ceased to be Director.
Ceased
Mahabir Prasad Agarwal ceased to be Director.
Appointed
Pranavkumar Sureshkumar Sharma was appointed as Director.
Appointed
Siddhesh Suresh Sharma was appointed as Director.
Appointed
Bharatbhushan Krishnakant Shrikhande was appointed as Director.
Incorporation
11 Sep 1986
Alintosch Pharmaceuticals Private Limited was registered on 11 Sep 1986 with Roc Mumbai & aged 40 years 2 months as per MCA records.

Frequently asked questions

Alintosch Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 September 1986 (40+ years old) and is registered under CIN U24230MH1986PTC040884.

Alintosch Pharmaceuticals has 3 current directors:

The latest financial statements of Alintosch Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Alintosch Pharmaceuticals is 27AAACA4487A3ZX, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Alintosch Pharmaceuticals is U24230MH1986PTC040884. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Alintosch Pharmaceuticals was incorporated on 11 September 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Alintosch Pharmaceuticals by revenue are Mebo Pharmaceutical (India) Private Limited, Moonlight Pharmaceuticals Private Limited, Answer Pharmaceuticals Private Limited, Alyssum Pharma Private Limited, Mega Biosciences Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Kalpana Suresh Sharma ceased to be Director on 31 Jan 2022. Sureshkumar Ramnarayan Sharma ceased to be Additional Director on 09 Sep 2016. Chandrashekhar Pashupatinath Karundia ceased to be Director on 28 May 2014. Alintosch Pharmaceuticals has 7 board changes on record in total.

The registered office of Alintosch Pharmaceuticals is at C704 Pramukh Plaza Cardinal Gracious Road Chakala Andheri East, Mumbai, Maharashtra, India – 400069.

Alintosch Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Alintosch Pharmaceuticals has open charges of ₹5 Cr and no satisfied charges on record as per latest MCA filings.